Back to the main directory
EarningsReview / Equity
- Capturing carbon''s value by BNP Paribas Exane
- 1Spatial - First wins for key SaaS product by Edison Investment Research
- Komplett (Hold, TP: NOK14.00) - New waiver may be needed by DnB Markets
- Getinge (Hold, TP: SEK215.00) - Another profit warning on quality by DnB Markets
- Primed for Upside, Raising Estimates by BNP Paribas Exane
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- An American in Paris by BNP Paribas Exane
- “Forever chemicals”: the next ESG controversy? by Oddo BHF
- musicMagpie - Margins improving despite volatile trading by Edison Investment Research
- Portobello SpA - Value appeal by Edison Investment Research
- Charging infrastructure: avoid blowing the low-carbon mobility circuit by Oddo BHF
- Back in the danger zone by BNP Paribas Exane
- Triple Point Energy Transition - FY23 results show fully covered 9% yield by Edison Investment Research
- Husqvarna (Hold, TP: SEK94.00) - Focus on what’s beyond 2023 by DnB Markets
- Skistar (Buy, TP: SEK134.00) - Tough Q3, but supportive outlook by DnB Markets
- Mixed signals from NCS production data by DnB Markets
- A trip to the proxologist by BNP Paribas Exane
- 2Q23 expected to be very strong, with 1H23 margin up by BNP Paribas Exane
- 1Q24 sales seen solid considering transition still ongoing by BNP Paribas Exane
- Nexi for the summer by BNP Paribas Exane
- 1H 23 preview: Moncler brand DTC in full motion by BNP Paribas Exane
- Atos – le probable statu quo lors de l’AG ne doit pas faire oublier les problèmes de gouvernance by Oddo BHF
- The probable status quo at the AGM should not overshadow the issues with the governance by Oddo BHF
- INVEST SECURITIES - GECINA : Cession opportuniste et pertinente du 101, avenue des Champs Elysées, ACHAT, OC 118€ by Invest Securities
- INVEST SECURITIES - URW : Lancement d'une offre d'échange sur la tranche 1 des titres hybrides, ACHAT, OC 78€ (vs 80€) by Invest Securities
- An un-FERG-iving point in the cycle by BNP Paribas Exane
- Creo Medical - CE extension nearly doubles addressable GI by Edison Investment Research
- Hexagon AB (Hold, TP: SEK140.00) - Time to w(AI)t by DnB Markets
- Many answers still pending by BNP Paribas Exane
- Memory Monthly: The Last Cut? by BNP Paribas Exane
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- Les « polluants éternels », la prochaine controverse ESG ? by Oddo BHF
- TCM Group - Strengthening the B2B position in Norway by Danske Bank Equity Research
- Infrastructures de recharge : éviter de faire disjoncter la mobilité bas-carbone by Oddo BHF
- Ultimovacs - Positive Phase I update in malignant melanoma by Edison Investment Research
- Itaú BBA on São Martinho: Neutral Results, In-Line 2023-24 Operating Guidance by Itau
- Spar Nord - Excellent earnings momentum continues by Danske Bank Equity Research
- Sats (Hold, TP: NOK12.00) - Summer lull by DnB Markets
- Norsk Hydro (Sell, TP: NOK55.00) - Global energy prices stabilising by DnB Markets
- Valuation update by DnB Markets
- CMD: Convincing technology, conservative top-line targets by BNP Paribas Exane
- Revising estimates higher again by BNP Paribas Exane
- It''s just too cheap by BNP Paribas Exane
- Q4 in-line, but weak FY24 guidance by BNP Paribas Exane
- CMD Post-mortem: Well I never! More for you, less for me. by BNP Paribas Exane
- Strategically positive - growth and focus by BNP Paribas Exane
- Break-up in sight? by BNP Paribas Exane
- SkiStar - Hold: Demand melted at the end of the winter season by Nordea
- INVEST SECURITIES - OSE IMMUNO : 1,5m€ de Bpifrance pour développer un test compagnon - ACHAT, OC 8,2€ by Invest Securities
- Helios Underwriting - Active Lloyd’s risk management and promotion by Edison Investment Research